Univest
Univest
  • Markets

5Paisa Capital Analyst Review 2027: Revenue Up 12%, Profit Down 26% and an MTF Book Growing 32%

  • November 17, 2026
  • Posted by: Kunal Singla
  • Category: Market
No Comments
5Paisa Capital Analyst Review 2027: Revenue Up 12%, Profit Down 26% and an MTF Book Growing 32%

5Paisa Capital Stock Snapshot (16 Nov 2026 close)

  • Current Market Price (CMP): ₹334.90
  • 52-Week High / Low: ₹416.95 / ₹245.50
  • Market Capitalisation: ₹1,571 crore
  • P/E Ratio vs Industry P/E: 37.6 vs 34.3
  • Latest Quarter (Q2 FY27) Revenue: ₹86.4 crore
  • Latest Quarter (Q2 FY27) Net Profit: ₹7.1 crore

Quick Answer: The 5Paisa Capital analyst review 2027 has no verified brokerage target, so it rests on reported numbers. Q2 FY27 revenue rose 12% to ₹86.4 crore, helped by a 32% jump in the margin trading book, but profit fell 25.5% to ₹7.1 crore. Core broking income was flat, while allied income grew 25%. At ₹334.90 the stock trades at a P/E of about 37.6 and 1.38 times book, with return on equity of just 3.7%.

The 5Paisa Capital analyst review 2027 covers a discount broker that is changing how it earns money. Anyone checking the 5Paisa Capital share price target 2027 will not find a verified brokerage call, but the September 2026 quarter showed the shift clearly. Revenue grew 12%, driven by margin lending and allied services, while broking fees went nowhere and profit fell.

5Paisa Capital is an online broker promoted by Nirmal Jain, founder of the IIFL group. It competes in a crowded market of low-cost apps. The stock, at ₹334.90, is 36% above its 52-week low of ₹245.50 but 20% below its high of ₹416.95.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Where Brokerages Stand in the 5Paisa Capital Analyst Review 2027
  • Latest Quarter Breakdown in the 5Paisa Capital Analyst Review 2027
  • Inside the 5Paisa Capital Business
  • Positive Triggers in the 5Paisa Capital Analyst Review 2027
  • What Could Go Wrong in the 5Paisa Capital Analyst Review 2027
  • 5Paisa Capital Analyst Review 2027: Valuation Snapshot
  • Ownership Pattern Over Five Quarters
  • Next Catalysts in the 5Paisa Capital Analyst Review 2027
  • Where the 5Paisa Capital Analyst Review 2027 Leaves Investors
  • Frequently Asked Questions
    • What is the short version of the 5Paisa Capital analyst review 2027?
    • Is there a 5Paisa Capital share price target 2027?
    • Which Q2 FY27 numbers drive the 5Paisa Capital analyst review 2027?
    • Why does the 5Paisa Capital analyst review 2027 show flat broking income?
    • Why does margin trading funding matter in the 5Paisa Capital analyst review 2027?
    • What could hurt the stock, according to the 5Paisa Capital analyst review 2027?
    • What should investors watch in the 5Paisa Capital stock outlook 2027?

Where Brokerages Stand in the 5Paisa Capital Analyst Review 2027

We could not find a dated, named brokerage rating or target price on 5Paisa Capital in recent months that we could verify. Coverage of smaller listed brokers is limited, partly because larger research houses compete in the same business. We have not used unverified targets.

Brokerage Rating Target Price Date
No verified recent coverage – – As of November 2026

This 5Paisa Capital analyst review 2027 instead uses the company’s Q2 FY27 investor presentation, results and shareholding data.

Latest Quarter Breakdown in the 5Paisa Capital Analyst Review 2027

Metric Q2 FY27 Q2 FY26 Change
Revenue ₹86.4 crore ₹77.3 crore +12%
Broking Income ₹34.9 crore ₹34.8 crore Flat
Allied Broking Income ₹24.4 crore About ₹19.5 crore +25%
EBITDA ₹21.8 crore ₹23.1 crore -5.5%
Net Profit ₹7.1 crore ₹9.5 crore -25.5%

Broking fees stayed flat, in line with cooler options activity across the industry after tighter derivatives rules. Growth instead came from allied income, which includes interest on margin trading funding (MTF), where the broker lends money to clients to buy shares. The MTF book grew 32% year on year.

Profit fell because costs climbed faster than revenue. The EBITDA margin dropped to about 25% from about 30%. Compared with the June 2026 quarter, revenue slipped 2% and profit fell from ₹11.6 crore to ₹7.1 crore. For the 5Paisa Capital analyst review 2027, cost control is the main issue.

Inside the 5Paisa Capital Business

A 5Paisa Capital share analysis rests on three income streams:

  • Broking income: Low flat fees per order on stocks, futures and options. Volume matters more than price.
  • Allied broking income: Interest on margin trading funding, interest on client funds and other related charges. This is now the fastest-growing stream.
  • Subscriptions and distribution: Paid plans, research packs and mutual fund and insurance distribution.

The 5Paisa Capital analyst review 2027 starts from scale. A discount broker spends heavily on technology and marketing, then earns small fees from a very large number of trades. When trading volumes fall, revenue falls fast but costs stay. That is why the shift toward MTF, which earns steady interest, matters for this 5Paisa Capital analyst review 2027.

The company is also building AI features. Management highlighted the launch of Ask 5paisa and a collaboration with OpenAI as part of its technology roadmap.

Positive Triggers in the 5Paisa Capital Analyst Review 2027

MTF growth: A 32% rise in the margin trading book adds interest income that is less tied to daily trading volumes.

AI-led engagement: Tools such as Ask 5paisa aim to keep users active and lift revenue per client.

Fresh capital: The company ran a rights issue in 2026, and promoter holding rose from 32.77% to 36.50% around that time, which suggests the promoters took up a large share.

Market participation: India’s investor base keeps growing, and any recovery in trading volumes would lift broking income quickly.

What Could Go Wrong in the 5Paisa Capital Analyst Review 2027

  • Regulation: Stricter rules on derivatives trading have already flattened broking income. Further changes could hurt more.
  • Competition: Larger rivals such as Angel One and other app-based brokers have bigger budgets and user bases.
  • Low returns: Return on equity of 3.7% is weak for a broker, and profit fell from ₹68.2 crore in FY25 to ₹44.2 crore in FY26.
  • Credit risk on MTF: Lending to clients carries risk if markets fall sharply and collateral loses value.
  • Market dependence: A weak market cuts both trading volumes and MTF demand.

Compare Broking Stocks on the Univest Screener

5Paisa Capital Analyst Review 2027: Valuation Snapshot

Parameter Value
Market Cap ₹1,571 crore
P/E (TTM) / Industry P/E 37.6 / 34.3
Price to Book 1.38
Book Value per Share ₹242.36
Return on Equity 3.7%
Debt to Equity 0.28
FY26 Revenue / Net Profit ₹320 crore / ₹44.2 crore

The P/E ratio of 37.6 is above the industry level of 34.3, while ROE is low. That combination means the market is pricing in a profit recovery. Revenue has fallen from ₹395 crore in FY24 to ₹320 crore in FY26, so the company needs growth to return before the valuation looks comfortable. Broker stocks also tend to move with sentiment in the wider Nifty Financial Services space.

Ownership Pattern Over Five Quarters

Holder Mar 2026 Apr 2026 Jun 2026 Sep 2026 Nov 2026
Promoters 32.77% 36.50% 36.50% 36.50% 34.97%
FIIs 12.41% 15.07% 15.11% 15.21% 15.23%
DIIs 0.01% 0.01% 0.00% 0.00% 0.00%
Public 54.81% 48.42% 48.38% 48.29% 49.80%

Promoter holding jumped in April 2026 and then eased to 34.97% in the November 2026 filing. Nirmal Jain holds 19.85% directly. Foreign investors raised their stake from 12.41% to 15.23%. For the 5Paisa Capital analyst review 2027, FII interest is a supportive sign, while the recent promoter dip is worth watching.

Univest iOS App

Univest Android App

Next Catalysts in the 5Paisa Capital Analyst Review 2027

  • Q3 FY27 results (around January 2027): Whether profit recovers toward the ₹11 to ₹12 crore range of earlier quarters.
  • MTF book: Continued growth and asset quality in margin lending.
  • Cost trend: Technology and marketing spending against revenue.
  • Derivative rules: Any further regulatory changes.
  • Promoter holding: Follow-up on the November 2026 dip.

Where the 5Paisa Capital Analyst Review 2027 Leaves Investors

The 5Paisa Capital analyst review 2027 shows a broker in transition. Margin lending and allied income are growing, and the Q2 FY27 results delivered 12% revenue growth. Flat broking fees, rising costs and a 25.5% fall in profit show how hard that transition is.

With no verified targets to guide the 5Paisa Capital stock outlook 2027, the company’s own numbers will decide the story. Profit recovery and better ROE would support the current valuation. Another weak quarter would make it harder to justify.

Disclaimer: This article is for educational and informational purposes only and is not investment advice or a recommendation to buy, sell or hold any security. Brokerage ratings and target prices quoted here are opinions of third-party research houses; Univest does not endorse them and gives no buy or sell call. Investments in the securities market are subject to market risks. Read all related documents carefully before investing. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.

Frequently Asked Questions

What is the short version of the 5Paisa Capital analyst review 2027?

The 5Paisa Capital analyst review 2027 shows a discount broker with rising revenue but falling profit and no verified brokerage coverage. Q2 FY27 revenue grew 12% to ₹86.4 crore. Profit fell 25.5% to ₹7.1 crore as costs rose. The margin trading book grew 32%.

Is there a 5Paisa Capital share price target 2027?

We could not verify any dated brokerage target for 5Paisa Capital in recent months. Research coverage of smaller brokers is thin. Investors can track profit recovery, MTF growth and ROE instead. Book value per share of about ₹242.36 is another reference point.

Which Q2 FY27 numbers drive the 5Paisa Capital analyst review 2027?

Revenue rose to ₹86.4 crore from ₹77.3 crore. Broking income was flat at ₹34.9 crore, while allied broking income grew 25% to ₹24.4 crore. EBITDA slipped to ₹21.8 crore. Net profit fell to ₹7.1 crore from ₹9.5 crore.

Why does the 5Paisa Capital analyst review 2027 show flat broking income?

Options activity across the industry has cooled after tighter derivatives rules, and options used to drive a large share of discount broker revenue. Broking income stayed at about ₹34.9 crore in Q2 FY27. Growth shifted to interest from margin trading funding. That changes how investors should value the company.

Why does margin trading funding matter in the 5Paisa Capital analyst review 2027?

Margin trading funding lets clients buy shares with money lent by the broker, who earns interest on the loan. 5Paisa Capital’s MTF book grew 32% in Q2 FY27. Interest income is steadier than trading fees. It does carry credit risk if markets fall sharply.

What could hurt the stock, according to the 5Paisa Capital analyst review 2027?

Regulation on derivatives, strong competition and weak ROE of 3.7% are the main risks. Profit fell from ₹68.2 crore in FY25 to ₹44.2 crore in FY26. MTF lending adds credit risk in a market fall. The P/E of 37.6 also assumes a recovery.

What should investors watch in the 5Paisa Capital stock outlook 2027?

The Q3 FY27 results, due around January 2027, will show whether profit recovers toward ₹11 to ₹12 crore. Growth and quality of the MTF book are key. Cost control and any new derivatives rules matter too. The promoter holding trend after the November 2026 dip will also shape the 5Paisa Capital analyst review 2027.



2027 5Paisa Capital Analyst Review stock broking
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply